Retatrutide

A high-purity triple GLP-1/GIP/glucagon receptor agonist studied for weight, metabolic and liver-fat outcomes. Third-party tested, 99% purity.

Retatrutide is a synthetic triple receptor agonist acting on the GLP-1, GIP and glucagon pathways — the extra glucagon pathway is linked to higher energy expenditure. Studied in the Phase 2/3 obesity and type-2-diabetes literature. Supplied as a lyophilized powder in a sterile vial. 99% purity. Third-party tested by Janoshik Analytical.